Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Dripping pills contg. (R)-3-[(S)-(5-oxyl-2-pyrrolidinyl)carbonyl]- thiazolidine-4-carboxyl, and its prepn. method

A technology of pyrrolidinyl and thiazolidine, which is applied in the field of medicine, can solve the problems of large size, inconvenient, and inconvenient to carry, and achieve the effects of high dissolution rate and dissolution rate, stable quality, and flexible dosage

Active Publication Date: 2006-01-25
SUZHOU SIXTH PHARMA PLANT OF JIANGSU WUZHONG PHARMA GROUP
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the commonly used dosage form is oral liquid, which is bulky and inconvenient to carry; granules and powders need to be ingested, and need to be dissolved when taking medicine, which is inconvenient

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0024] A preparation method of a drop pill dosage form containing (R)-3-[(S)-(5-oxo-2-pyrrolidinyl) carbonyl]-thiazolidine-4-carboxyl (pidotimod), which comprises Follow the steps below:

[0025] First take the substrate and heat it to a molten state, then add (R)-3-[(S)-(5-oxo-2-pyrrolidinyl)carbonyl]-thiazolidine containing 15 to 75% water to the molten substrate - 4-carboxy (pidotimod) suspension, stirred evenly, dripped into the cooling liquid under heat preservation conditions to condense into pellets, removed the cooling liquid, and dried to get the drop pill core; the cooling liquid includes simethicone , liquid paraffin, vegetable oil or a mixture thereof.

[0026] When heating, first take the substrate and heat it to a molten state, then add (R)-3-[(S)-(5-oxo-2-pyrrolidinyl)carbonyl]-thiazolidine-4-carboxyl to the molten substrate (pidotimod), heated to make it into a solution, stirred evenly, dripped into the cooling liquid under the condition of heat preservation,...

Embodiment 1

[0028] Pidotimod 10g

[0029] water 10g

[0030] Macrogol 6000 160g

[0031] Tween-80 1.5g

[0032] Proper amount of hypromellose

Embodiment 2

[0034] Pidotimod 10g

[0035] water 2g

[0036] Monostearic acid 200g

[0037] Appropriate amount of polyvinyl alcohol phthalate

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A dripping pill containing (R)-3-[(S)-(5-oxy-2-pyrrolidine) carboxyl]-thiazolidine-4-carboxyl (Piduomode) is prepared from (R)-3-[(S)-(5-oxy-2-pyrrolidine) carboxyl]-thiazolidine-4-carboxyl (Piduomode) and matrix through proportional mixing, dripping into cooling liquid and drying.

Description

technical field [0001] The invention belongs to the technical field of medicine, in particular to an immunostimulatory regulator (R)-3-[(S)-(5-oxo-2-pyrrolidinyl)carbonyl]-thiazolidine-4-carboxyl (Pidol Moder) drop pills for the treatment of patients with cellular immune dysfunction. Background technique [0002] (R)-3-[(S)-(5-oxo-2-pyrrolidinyl)carbonyl]-thiazolidine-4-carboxyl (pidotimod, pidotimod in English), is a fully synthetic immunostimulatory Modulators, which produce effects by stimulating and modulating cellular immunity. The adult preventive dose is 800mg each time, once a day. (R)-3-[(S)-(5-Oxo-2-pyrrolidinyl)carbonyl]-thiazolidine-4-carboxy (pidotimod) has been on the market in Europe since 1994, basic experiments and clinical results It shows that it is more prominent in improving the anti-infection immune function of the body than previous immune boosters. (R)-3-[(S)-(5-oxo-2-pyrrolidinyl)carbonyl]-thiazolidine-4-carboxy (pidot...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/427A61K9/20A61P37/02
Inventor 刘志祥米靖宇王金陵阎政戈冬眠杨南林
Owner SUZHOU SIXTH PHARMA PLANT OF JIANGSU WUZHONG PHARMA GROUP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com